BlackRock
EXAS

BlackRock’s Exact Sciences EXAS Stock Holding History

BlackRock’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-15,134,118
Closed -$1.54B – 5718
2025
Q4 		$1.54B Buy
15,134,118
+4,571,957
+43% +$367M 0.03% 507
2025
Q3 		$578M Buy
10,562,161
+29,561
+0.3% +$1.48M 0.01% 1001
2025
Q2 		$560M Sell
10,532,600
-1,388,121
-12% -$70.5M 0.01% 984
2025
Q1 		$516M Buy
11,920,721
+50,759
+0.4% +$2.57M 0.01% 1009
2024
Q4 		$667M Buy
11,869,962
+601,627
+5% +$37.4M 0.01% 882
2024
Q3 		$768M Sell
11,268,335
-797,523
-7% -$45M 0.02% 778
2024
Q2 		$510M Buy
12,065,858
+689,762
+6% +$38M 0.01% 990
2024
Q1 		$786M Buy
11,376,096
+323,083
+3% +$20.4M 0.02% 733
2023
Q4 		$818M Sell
11,053,013
-522,545
-5% -$34.3M 0.02% 671
2023
Q3 		$790M Buy
11,575,558
+402,846
+4% +$34.2M 0.02% 632
2023
Q2 		$1.05B Buy
11,172,712
+519,159
+5% +$40.5M 0.03% 521
2023
Q1 		$722M Sell
10,653,553
-701,005
-6% -$45.1M 0.02% 685
2022
Q4 		$562M Buy
11,354,558
+916,620
+9% +$37.5M 0.02% 803
2022
Q3 		$339M Buy
10,437,938
+418,605
+4% +$17.3M 0.01% 1084
2022
Q2 		$395M Buy
10,019,333
+229,781
+2% +$12.3M 0.01% 1026
2022
Q1 		$684M Buy
9,789,552
+292,540
+3% +$21.4M 0.02% 759
2021
Q4 		$739M Buy
9,497,012
+824,511
+10% +$72.8M 0.02% 750
2021
Q3 		$828M Sell
8,672,501
-268,898
-3% -$28.4M 0.02% 658
2021
Q2 		$1.11B Sell
8,941,399
-61,014
-0.7% -$7.28M 0.03% 550
2021
Q1 		$1.19B Buy
9,002,413
+713,935
+9% +$97.7M 0.03% 510
2020
Q4 		$1.1B Buy
8,288,478
+488,584
+6% +$59.1M 0.04% 483
2020
Q3 		$795M Sell
7,799,894
-179,161
-2% -$15.5M 0.03% 550
2020
Q2 		$694M Buy
7,979,055
+248,764
+3% +$19.9M 0.03% 557
2020
Q1 		$448M Sell
7,730,291
-54,216
-0.7% -$4.4M 0.02% 661
2019
Q4 		$720M Buy
7,784,507
+736,119
+10% +$64.7M 0.03% 604
2019
Q3 		$637M Buy
7,048,388
+97,538
+1% +$11.1M 0.03% 609
2019
Q2 		$820M Buy
6,950,850
+1,273,108
+22% +$128M 0.04% 507
2019
Q1 		$492M Buy
5,677,742
+101,718
+2% +$8.66M 0.02% 743
2018
Q4 		$352M Buy
5,576,024
+469,499
+9% +$32.2M 0.02% 878
2018
Q3 		$403M Sell
5,106,525
-80,768
-2% -$5.27M 0.02% 915
2018
Q2 		$310M Sell
5,187,293
-2,460,393
-32% -$132M 0.01% 1089
2018
Q1 		$308M Sell
7,647,686
-10,459
-0.1% -$510K 0.01% 1047
2017
Q4 		$402M Buy
7,658,145
+126,513
+2% +$6.76M 0.02% 839
2017
Q3 		$355M Buy
7,531,632
+646,746
+9% +$26M 0.02% 892
2017
Q2 		$244M Buy
6,884,886
+80,589
+1% +$2.49M 0.01% 1134
2017
Q1 		$161M Buy
6,804,297
+6,789,478
+45,816% +$135M 0.01% 1457
2016
Q4 		$198K Sell
14,819
-497
-3% -$8.02K ﹤0.01% 2150
2016
Q3 		$285K Buy
15,316
+5,769
+60% +$102K ﹤0.01% 1972
2016
Q2 		$116K Buy
9,547
+3,097
+48% +$23.3K ﹤0.01% 2449
2016
Q1 		$43K Sell
6,450
-653
-9% -$4.18K ﹤0.01% 2443
2015
Q4 		$65K Buy
7,103
+4,852
+216% +$45.1K ﹤0.01% 1917
2015
Q3 		$40K Hold
2,251
– – ﹤0.01% 2003
2015
Q2 		$67K Hold
2,251
– – ﹤0.01% 1885
2015
Q1 		$50K Sell
2,251
-305
-12% -$7.74K ﹤0.01% 1949
2014
Q4 		$70K Hold
2,556
– – ﹤0.01% 1830
2014
Q3 		$50K Hold
2,556
– – ﹤0.01% 1912
2014
Q2 		$43K Buy
2,556
+783
+44% +$10.8K ﹤0.01% 2003
2014
Q1 		$25K Buy
1,773
+110
+7% +$1.49K ﹤0.01% 2242
2013
Q4 		$20K Hold
1,663
– – ﹤0.01% 2358
2013
Q3 		$20K Hold
1,663
– – ﹤0.01% 2274
2013
Q2 		$23K Buy
+1,663
New +$18.1K ﹤0.01% 2227

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

BlackRock's EXAS Position: Q1 2026 in Review

BlackRock sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 15,134,118 shares — an estimated $1.54B sold.

BlackRock first reported a position in EXAS in Q2 2013 and held it in 51 quarters. The position peaked at $1.54B in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • BlackRock reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • BlackRock sold 15,134,118 Exact Sciences shares in Q1 2026, an estimated $1.54B.
  • BlackRock first reported a position in Exact Sciences in Q2 2013 and held it in 51 quarters.
  • BlackRock's Exact Sciences position peaked at $1.54B in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.